Pneumonia Diagnostics Market Advances with AI-Based Imaging Solutions
The global pneumonia diagnostics market is poised for significant growth, driven by advances in medical technologies, increased awareness, and the rising global burden of pneumonia. With an estimated value of US$ 2.5 billion in 2026, the market is projected to reach US$ 4.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.4% over the forecast period from 2026 to 2033. This surge is expected to be fueled by innovations in diagnostic tools, an increase in respiratory diseases, and a rising demand for rapid, accurate testing methods.